Albert David Limited Reports Mixed Q1 FY2026 Results with Decline in Revenue and Profit Aug 04, 2025
Albert David Limited Appoints Pharma Veteran as New Independent Director, Approves Q1 Results Aug 02, 2025
More news about Albert David
02Aug 25
Albert David Reports 59% Decline in Q1 Net Profit, Appoints New Independent Director
Albert David Limited's Q1 net profit declined by 59.30% to ₹77.50 million from ₹190.40 million year-over-year. The Board approved Q1 financial results and appointed Dr. Rajiv Anant Desai as Additional Non-Executive Independent Director for five years, effective August 2, subject to shareholder approval. Dr. Desai brings 38 years of pharmaceutical industry experience, including roles at Indian Pharmaceutical Alliance and Lupin Limited.
13May 25
Albert David Ltd Reports Q4 FY23 Results: EBITDA Loss Widens, Revenue Declines; Recommends Dividend
Albert David Ltd's Q4 FY23 results show a 15.94% YoY revenue decline to ₹749.00 crore. EBITDA swung to a loss of ₹48.00 crore from a profit of ₹96.00 crore in Q4 FY22. Net loss improved by 20.16% YoY to ₹103.00 crore. The company recommended a dividend of ₹5 per equity share despite financial challenges.